Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
21.26
+0.08 (0.38%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Biodesix Employees
Biodesix had 334 employees as of December 31, 2025. The number of employees increased by 61 or 22.34% compared to the previous year. That makes Biodesix the 23,040th largest employer in the world and 2,980th in the United States.
Employees
334
Change (1Y)
61
Growth (1Y)
22.34%
Revenue / Employee
$308,201
Profits / Employee
-$83,120
Market Cap
224.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 334 | 61 | 22.34% |
| Dec 31, 2024 | 273 | 56 | 25.81% |
| Dec 31, 2023 | 217 | -28 | -11.43% |
| Dec 31, 2022 | 245 | 27 | 12.39% |
| Dec 31, 2021 | 218 | 18 | 9.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| Castle Biosciences | 1,002 |
| Burning Rock Biotech | 667 |
| Freenome | 381 |
| Exagen | 220 |
BDSX News
- 5 days ago - Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026 - GlobeNewsWire
- 7 days ago - American College of Chest Physicians Publishes New Framework for Lung Nodule Programs Recommending Biomarkers for Risk Stratification - GlobeNewsWire
- 8 days ago - Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers - GlobeNewsWire
- 14 days ago - Biodesix price target raised to $40 from $30 at TD Cowen - TheFly
- 14 days ago - Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026 - GlobeNewsWire
- 4 weeks ago - Biodesix price target raised to $38 from $27 at H.C. Wainwright - TheFly
- 4 weeks ago - Biodesix advances two programs for Molecular Residual Disease monitoring - TheFly
- 4 weeks ago - Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring - GlobeNewsWire